MidMarketNow
Get the Weekly

Sobi

—

Sectors—
Regions—
Last activity

Activity, last 12 months

Sobi — events per month, last 12 months
Sobi — events per month, last 12 months
MonthEvents
August 20250
September 20250
October 20250
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260

Deal history

  1. Sobi bets big on next‑gen gout leader Arthrosi

    Sobi’s acquisition of Arthrosi Therapeutics, anchored by Phase 3 URAT1 inhibitor AR882, marks a decisive move to build a global gout franchise and signals intensifying competition in next‑generation gout therapeutics.

We use privacy-respecting product analytics to understand how readers use MidMarketNow and improve it. No personal data (email, IP) is sent. See our privacy policy.